Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

4'-C-Trifluoromethyl modified oligodeoxynucleotides: synthesis, biochemical studies, and cellular uptake properties.

Zhou Y, Zang C, Wang H, Li J, Cui Z, Li Q, Guo F, Yan Z, Wen X, Xi Z, Zhou C.

Org Biomol Chem. 2019 Jun 5;17(22):5550-5560. doi: 10.1039/c9ob00765b.

PMID:
31112186
3.

Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.

Hanagata N.

Int J Nanomedicine. 2012;7:2181-95. doi: 10.2147/IJN.S30197. Epub 2012 Apr 27. Review.

4.

Solid-phase synthesis, thermal denaturation studies, nuclease resistance, and cellular uptake of (oligodeoxyribonucleoside)methylborane phosphine-DNA chimeras.

Krishna H, Caruthers MH.

J Am Chem Soc. 2011 Jun 29;133(25):9844-54. doi: 10.1021/ja201314q. Epub 2011 Jun 7.

PMID:
21585202
5.

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.

J Natl Cancer Inst. 1996 Apr 3;88(7):419-29.

PMID:
8618233
7.

2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.

Yoo BH, Bochkareva E, Bochkarev A, Mou TC, Gray DM.

Nucleic Acids Res. 2004 Apr 2;32(6):2008-16. Print 2004.

8.
9.

Modulation of pyrene fluorescence in DNA probes depends upon the nature of the conformationally restricted nucleotide.

Honcharenko D, Zhou C, Chattopadhyaya J.

J Org Chem. 2008 Apr 4;73(7):2829-42. doi: 10.1021/jo702747w. Epub 2008 Mar 11.

PMID:
18331060
10.

Effects of 2'-O-(trifluoromethyl)adenosine on oligodeoxynucleotide hybridization and nuclease stability.

Nishizono N, Sumita Y, Ueno Y, Matsuda A.

Nucleic Acids Res. 1998 Nov 15;26(22):5067-72.

11.

Modulation of allergic response in nasal mucosa by antisense oligodeoxynucleotides for IL-4.

Fiset PO, Soussi-Gounni A, Christodoulopoulos P, Tulic M, Sobol SE, Frenkiel S, Lavigne F, Lamkhioued B, Hamid Q.

J Allergy Clin Immunol. 2003 Mar;111(3):580-6.

PMID:
12642840
12.

Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.

Brown DA, Kang SH, Gryaznov SM, DeDionisio L, Heidenreich O, Sullivan S, Xu X, Nerenberg MI.

J Biol Chem. 1994 Oct 28;269(43):26801-5.

14.
15.

Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.

Matsuoka N, Nishikawa M, Mohri K, Rattanakiat S, Takakura Y.

J Control Release. 2010 Dec 20;148(3):311-6. doi: 10.1016/j.jconrel.2010.09.019. Epub 2010 Sep 29.

PMID:
20887761
16.
17.

Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.

Meng W, Yamazaki T, Nishida Y, Hanagata N.

BMC Biotechnol. 2011 Sep 26;11:88. doi: 10.1186/1472-6750-11-88.

20.

Supplemental Content

Support Center